Biotechnology company TenNor Therapeutics jumped 48% in Hong Kong’s grey market trading.
TenNor Therapeutics is a near-commercial stage biotechnology company, incorporated in 2013 and focused on the development, manufacturing, and commercialization of innovative anti-infective drugs. The company addresses critical unmet needs in infectious diseases, with an emphasis on multi-drug resistant pathogens.